These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12530632)
1. Protein serine/threonine phosphatase 2A activity is inhibited by cAMP in MA-10 cells. Poderoso C; Paz C; Gorostizaga A; Cornejo Maciel F; Mendez CF; Podesta EJ Endocr Res; 2002 Nov; 28(4):319-23. PubMed ID: 12530632 [TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatases are involved in LH/chorionic gonadotropin and 8Br-cAMP regulation of steroidogenesis and StAR protein levels in MA-10 Leydig cells. Paz C; Cornejo Maciel F; Maloberti P; Walsh LP; Stocco DM; Podestá EJ J Endocrinol; 2002 Dec; 175(3):793-801. PubMed ID: 12475389 [TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676 [TBL] [Abstract][Full Text] [Related]
5. cAMP regulation of protein phosphatases PP1 and PP2A in brain. Leslie SN; Nairn AC Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):64-73. PubMed ID: 30401536 [TBL] [Abstract][Full Text] [Related]
6. Role of phosphoprotein phosphatases in the corpus luteum: II control of progesterone secretion by isolated rat luteal cells. Abayasekara DR; Ford SL; Persaud SJ; Jones PM J Endocrinol; 1996 Aug; 150(2):213-21. PubMed ID: 8869588 [TBL] [Abstract][Full Text] [Related]
7. Interdependence of steroidogenesis and shape changes in Y1 adrenocortical cells: studies with inhibitors of phosphoprotein phosphatases. Whitehouse BJ; Gyles SL; Squires PE; Sayed SB; Burns CJ; Persaud SJ; Jones PM J Endocrinol; 2002 Mar; 172(3):583-93. PubMed ID: 11874707 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A. Resjö S; Oknianska A; Zolnierowicz S; Manganiello V; Degerman E Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):839-45. PubMed ID: 10417351 [TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-induced expression of steroidogenic acute regulatory protein is dependent upon phosphoprotein phosphatase activities. Jones PM; Sayed SB; Persaud SJ; Burns CJ; Gyles S; Whitehouse BJ J Mol Endocrinol; 2000 Apr; 24(2):233-9. PubMed ID: 10750024 [TBL] [Abstract][Full Text] [Related]
10. Role of phosphoprotein phosphatases in the corpus luteum: I identification and characterisation of serine/threonine phosphoprotein phosphatases in isolated rat luteal cells. Ford SL; Abayasekara DR; Persaud SJ; Jones PM J Endocrinol; 1996 Aug; 150(2):205-11. PubMed ID: 8869587 [TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase inhibitor cantharidin inhibits steroidogenesis and steroidogenic acute regulatory protein expression in cultured rat preovulatory follicles. Yu CC; Chen WY; Li PS Life Sci; 2001 Nov; 70(1):57-72. PubMed ID: 11764007 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of serine/threonine protein phosphatases enhances agonist-stimulated cAMP accumulation in UMR 106 osteoblast-like cells. Kovacs CS; Chik CL; Li B; Karpinski E; Ho AK Mol Cell Endocrinol; 1995 Apr; 110(1-2):9-16. PubMed ID: 7545625 [TBL] [Abstract][Full Text] [Related]
13. Differential inhibitory effects of serine/threonine phosphatase inhibitors and a calmodulin antagonist on phosphoinositol/calcium- and cyclic adenosine monophosphate-mediated pancreatic amylase secretion. Meyer-Alber A; Höcker M; Fetz I; Fornefeld H; Waschulewski IH; Fölsch UR; Schmidt WE Scand J Gastroenterol; 1995 Apr; 30(4):384-91. PubMed ID: 7541915 [TBL] [Abstract][Full Text] [Related]
14. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855 [TBL] [Abstract][Full Text] [Related]
15. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A. McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131 [TBL] [Abstract][Full Text] [Related]
16. Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts. Alberts AS; Montminy M; Shenolikar S; Feramisco JR Mol Cell Biol; 1994 Jul; 14(7):4398-407. PubMed ID: 7516466 [TBL] [Abstract][Full Text] [Related]
17. Effects of serine/threonine protein phosphatase inhibitors on morphine-induced antinociception in the tail flick test in mice. Moncada A; Cendán CM; Baeyens JM; Del Pozo E Eur J Pharmacol; 2003 Mar; 465(1-2):53-60. PubMed ID: 12650833 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Woetmann A; Nielsen M; Christensen ST; Brockdorff J; Kaltoft K; Engel AM; Skov S; Brender C; Geisler C; Svejgaard A; Rygaard J; Leick V; Odum N Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10620-5. PubMed ID: 10485875 [TBL] [Abstract][Full Text] [Related]
19. Phosphoprotein phosphatases regulate steroidogenesis by influencing StAR gene transcription. Burns CJ; Gyles SL; Persaud SJ; Sugden D; Whitehouse BJ; Jones PM Biochem Biophys Res Commun; 2000 Jun; 273(1):35-9. PubMed ID: 10873559 [TBL] [Abstract][Full Text] [Related]
20. Characterization of protein serine/threonine phosphatase activities in human lung mast cells and basophils. Peirce MJ; Munday MR; Peachell PT Br J Pharmacol; 1998 Nov; 125(5):1095-101. PubMed ID: 9846650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]